- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2024
- 184 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2338EUR$2,450USD£1,959GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
The Cholera Test market is a subset of the larger Infectious Disease Testing market. It is used to detect the presence of the bacterium Vibrio cholerae, which is the cause of the disease cholera. Cholera is an acute diarrheal infection that can cause severe dehydration and even death if left untreated. Cholera tests are used to diagnose the disease in both symptomatic and asymptomatic individuals. Tests are typically performed on stool samples, and can be done using either culture or molecular methods.
The Cholera Test market is composed of a variety of companies that provide testing services and products. These include diagnostic companies such as Bio-Rad Laboratories, DiaSorin, and Meridian Bioscience, as well as manufacturers of test kits such as Alere, BioFire Diagnostics, and Cepheid. Show Less Read more